The overexpression of CLDN4 has been reported in various cancers, including gastric cancer, pancreatic cancer, colorectal cancer, breast cancer, oral squamous cell carcinoma, ovarian cancer, bladder cancer, cholangiocarcinoma, and NSCLC. This evidence concerns the gene CLDN4 and non-small cell lung carcinoma.